山西科新发展股份有限公司重大股权变动：连宗盛增持股份并豁免要约收购义务

一、事件概述与核心要点

近日，山西科新发展股份有限公司（简称“科新发展”，股票代码：600234）发布收购报告书摘要，披露公司控股股东及实际控制人连宗盛先生通过认购公司向特定对象发行股份的方式，进一步增持公司股份。此次收购完成后，连宗盛及其一致行动人持股比例将超过30%，并已承诺36个月内不转让新股，拟豁免要约收购义务。

二、收购人及一致行动人详细信息

• 收购人： 连宗盛，现任多家投资及实业公司的董事和总经理，控制多个投资主体，无境外永久居留权，近五年无重大行政或刑事处罚，也未有重大诉讼及仲裁记录。
• 一致行动人：
  • 深圳市科新实业控股有限公司，注册资本6亿元，连宗盛持股99%，主营投资、贸易、供应链管理等。2024年7月实际控制人由黄绍嘉变更为连宗盛。
  • 深圳市派德壹盛投资合伙企业（有限合伙），注册资本4亿元，连宗盛通过控制壹盛合元实业有限公司间接持有99%权益，主营创业投资及项目投资。

三、交易结构及股份变动

发行股份数量及价格：
本次科新发展向连宗盛定向发行26,252,097股A股，发行价格为11.48元/股，总金额为约3.01亿元人民币。发行价格不低于定价基准日前20个交易日均价的80%，若期间公司发生派息、送股、资本公积转增股本等事项，价格将相应调整。

股份变动前后对比：
发行前，连宗盛及其一致行动人合计持有74,113,691股，占总股本28.23%。发行后，合计持有100,365,788股，占总股本34.76%。

限售安排：
连宗盛认购股份自发行结束之日起36个月内不得转让。相关衍生股份（如分红派息、转增等）亦受相同限售安排。

四、免于要约收购的豁免安排

根据《上市公司收购管理办法》第六十三条，若投资者承诺36个月内不转让新股，并获公司股东会非关联股东通过，可免于发出要约收购。本次收购已满足相关条件，科新发展董事会已提请股东会批准对连宗盛的豁免要约收购。

五、收购目的及对公司影响

• 巩固控股地位，进一步提升公司治理稳定性。
• 增强公司资金实力，满足核心业务发展需求。
• 优化股权结构，提高抗风险能力，推动公司持续稳定发展。

六、后续决策流程与审批进展

• 2026年3月13日，公司第十届董事会第八次临时会议审议通过发行议案。
• 本次发行须经公司股东会、上海证券交易所审核通过，并取得中国证监会同意注册的批复。
• 相关审批存在不确定性，投资者需关注交易审批风险。

七、财务数据简要披露（2023-2025年）

八、对投资者和股价的潜在影响

• 控股股东及实控人地位进一步巩固，有助于公司稳定发展。
• 本次定向增发将为公司补充流动资金，提升抗风险和持续经营能力。
• 股份三年锁定，有助于稳定市场预期，减轻短期抛压。
• 若未通过相关监管和股东会审议，交易可能无法实施，构成不确定性风险。
• 豁免要约收购义务能有效避免大规模强制要约带来的流动性冲击，有利于保护中小股东利益。

九、其他重要事项

• 截至摘要签署日，连宗盛及一致行动人持有股份不存在质押、冻结等权利限制。
• 所披露信息真实、准确、完整，收购人及一致行动人承担法律责任。

十、投资者提示

本次收购涉及的股份发行及豁免要约收购尚需多项监管和公司治理流程通过，存在一定不确定性。请投资者高度关注相关后续公告，理性评估投资风险。

免责声明

本文内容仅供参考，不构成任何投资建议。相关信息以公司正式公告及监管部门批复为准。投资有风险，决策请谨慎。

English Version

Key Takeaways: Lian Zongsheng Increases Stake in Shanxi Kexin Development, Seeks Exemption from Mandatory Offer

1. Overview and Key Highlights

Shanxi Kexin Development Co., Ltd. (stock code: 600234) has disclosed a significant shareholding change. Major shareholder and de facto controller, Mr. Lian Zongsheng, will further increase his holdings by subscribing to a private placement of company shares. Upon completion, Lian and his concerted parties will hold more than 30% of total shares. Lian has committed not to transfer these new shares for 36 months and seeks exemption from making a mandatory general offer.

2. Details of Acquirer and Concerted Parties

• Acquirer: Lian Zongsheng, director/general manager of several investment and industrial companies, holds no overseas permanent residency, and has a clean regulatory and legal record in the past five years.
• Concerted Parties:
  • Shenzhen Kexin Industrial Holdings Co., Ltd. (Registered capital: RMB 600m), 99% owned by Lian. Changed actual controller from Huang Shaojia to Lian in July 2024.
  • Shenzhen Paide Yisheng Investment LP (Registered capital: RMB 400m), 99% indirectly controlled by Lian, focusing on VC and project investment.

3. Transaction Structure and Share Changes

Number and Price of Shares:
26,252,097 new A-shares to be issued to Lian at RMB 11.48/share, totaling approximately RMB 301.37 million. The price is not lower than 80% of the average trading price in the 20 trading days preceding the pricing benchmark date. The price will be adjusted for ex-rights events.

Pre- and Post-Issuance Holding:
Before: Lian and concert parties held 74,113,691 shares (28.23%).
After: Expected to hold 100,365,788 shares (34.76%).

Lock-up:
Shares subscribed by Lian are subject to a 36-month lock-up period from the date of completion.

4. Exemption from Mandatory Offer

According to regulations, if the investor commits to a 36-month non-transfer period for the new shares and the deal is approved by non-related shareholders, they may be exempt from making a general offer. The deal meets these criteria and the board has submitted the exemption for shareholder approval.

5. Purpose and Impact

• Consolidates control and enhances governance stability.
• Strengthens company’s capital base for core business and risk resilience.
• Optimizes equity structure and supports sustainable growth.

6. Approval Process and Timeline

• Board approval obtained on March 13, 2026.
• Still requires shareholder meeting, Shanghai Stock Exchange, and CSRC registration.
• Implementation is uncertain—investors should monitor progress.

7. Brief Financials (2023-2025)

8. Potential Impact on Investors and Share Price

• Further consolidates control, stabilizing governance and outlook.
• Capital injection improves liquidity and resilience.
• 36-month lock-up supports share price stability, reducing short-term selling pressure.
• Approval risks remain—transaction may not proceed if not approved.
• Exemption from mandatory offer prevents potential market disruption, protecting minority shareholders.

9. Other Important Matters

• As of the disclosure date, there are no pledges, freezes, or other restrictions on shares held by Lian and concert parties.
• Information disclosed is complete and accurate, with legal responsibility assumed by relevant parties.

10. Investor Notice

The transaction and exemption remain subject to multiple regulatory and shareholder approvals. Uncertainty exists—please follow company updates and assess risks prudently.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Please refer to official company announcements and regulatory approvals. Investments carry risks—make decisions cautiously.

View 科新发展 Historical chart here